Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
241,507,506
-
Share change
-
+4,061,429
-
Total reported value
-
$1,786,983,312
-
Put/Call ratio
-
145%
-
Price per share
-
$7.40
-
Number of holders
-
294
-
Value change
-
+$22,988,107
-
Number of buys
-
133
-
Number of sells
-
119
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2024
As of 31 Dec 2024 IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) had 294 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 241,507,506 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, MHR FUND MANAGEMENT LLC, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, STATE STREET CORP, Hood River Capital Management LLC, Soleus Capital Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, T. Rowe Price Investment Management, Inc., and Long Focus Capital Management, LLC.
This table shows 294 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.